Vivo Capital Fund IX, L.P.
CIK 1750117 · last filed 2023-08-10
Vivo Capital Fund IX, L.P. is a corporate insider who has filed 8 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing shows the insider bought $24.0M of IOBT on Aug 10, 2023. Across all open-market trades the lifetime net is +$45.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $452.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$452.30M
3
8
$44.99M
Holdings By Company
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-10 | IO Biotech, Inc. (IOBT) Delisted | Buy (P) | +12,631,576 | $24.00M | EDGAR |
| 2022-05-05 | TARS | Sell (S) | −10,748 | -$131.7K | EDGAR |
| 2022-05-04 | TARS | Sell (S) | −1,025,912 | -$13.73M | EDGAR |
| 2021-11-12 | IO Biotech, Inc. (IOBT) Delisted | Mixed | +6,031,090 | $18.20M | EDGAR |
| 2021-06-25 | TARS | Sell (S) | −111,368 | -$3.32M | EDGAR |
| 2021-04-16 | TARS | Sell (S) | −800 | -$24.3K | EDGAR |
| 2021-03-25 | TIL | Mixed | +24,973,574 | $12.00M | EDGAR |
| 2020-10-20 | TARS | Mixed | +6,490,070 | $8.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.